114 related articles for article (PubMed ID: 2616358)
1. [Hemodialysis and the regulation of immunologic response in chronic uremia].
Luciak M
Pol Arch Med Wewn; 1989 Feb; 81(2):65-9. PubMed ID: 2616358
[No Abstract] [Full Text] [Related]
2. Hemofiltration and the middle molecule.
Henderson LW
Blood Purif; 1999; 17(4):175-7. PubMed ID: 10494018
[No Abstract] [Full Text] [Related]
3. Are biocompatible membranes superior for hemodialysis therapy?
van Ypersele de Strihou C
Kidney Int Suppl; 1997 Nov; 62():S101-4. PubMed ID: 9350694
[No Abstract] [Full Text] [Related]
4. Level of the C3c complement in uremic patients hemodialyzed with three different dialyzer membranes, prior to the dialysis seance.
Krawczyk W; Marczewski K; Ledwozyw A
Clin Nephrol; 1995 Nov; 44(5):340. PubMed ID: 8605718
[No Abstract] [Full Text] [Related]
5. Induction of mRNA for tumor necrosis factor alpha in hemodialysis.
Roccatello D; D'Alfonso S; Peruccio D; Quattrocchio G; Cavalli G; Isidoro C; Piccoli G; Richiardi PM
Kidney Int Suppl; 1993 Jan; 39():S144-8. PubMed ID: 8468917
[No Abstract] [Full Text] [Related]
6. Increased risk of malignancy and blood-membrane interactions in uraemic patients.
Akizawa T; Kinugasa E; Koshikawa S
Nephrol Dial Transplant; 1994; 9 Suppl 2():162-4. PubMed ID: 8065609
[No Abstract] [Full Text] [Related]
7. [Pathophysiological and clinical aspects of blood-biological material interactions in hemodialysis therapy].
Trznadel K
Pol Arch Med Wewn; 1988 Nov; 80(5):294-300. PubMed ID: 3271332
[No Abstract] [Full Text] [Related]
8. [Amembris: a new fiber for optimal clearance of a wide spectrum of middle molecules].
G Ital Nefrol; 2013; 30(2):. PubMed ID: 25077343
[No Abstract] [Full Text] [Related]
9. Cytokine production in standard hemodialysis with a new polyethersulfone membrane: a cross-over study.
Memoli B; Bisesti V; Saravo MT; Esposito P; D'Arcangelo R; Nicosia V; Clienti C; Andreucci M; Esposito A; Tetta C
Contrib Nephrol; 2003; (138):80-7. PubMed ID: 12463149
[No Abstract] [Full Text] [Related]
10. Immune dysfunction and cytokine production in hemodialysis. Could they be lessened by vitamin E-coated dialyzer membrane?
Senatore M; Cecere P; Colombo P; Costantini L; Filiberti O; Piccini G; Peona C; Buemi M; Nicoletti A; Rizzuto G
Nephron; 2002 Dec; 92(4):758-62. PubMed ID: 12399618
[No Abstract] [Full Text] [Related]
11. [Effects of hemodialysis with different membranes on blood serum nitrite/nitrate concentrations].
Rysz J; Błaszczak R; Zalewski A
Pol Arch Med Wewn; 2002 Feb; 107(2):121-3. PubMed ID: 12107966
[TBL] [Abstract][Full Text] [Related]
12. Patient survival on PAN/AN 69 membrane hemodialysis.
Chanard J
J Am Soc Nephrol; 1994 Jun; 4(12):2050-1. PubMed ID: 7919158
[No Abstract] [Full Text] [Related]
13. [Immune response in uremia].
Sobczyk J
Pol Tyg Lek; 1978 Sep; 33(37):1475-8. PubMed ID: 360191
[No Abstract] [Full Text] [Related]
14. Acute hemolysis following hemodialysis.
Ivanovich P; Manzler A; Drake R
Trans Am Soc Artif Intern Organs; 1969; 15():316-20. PubMed ID: 5791403
[No Abstract] [Full Text] [Related]
15. Can convective therapies improve dialysis outcomes?
Locatelli F; Manzoni C; Cavalli A; Di Filippo S
Curr Opin Nephrol Hypertens; 2009 Nov; 18(6):476-80. PubMed ID: 19726986
[TBL] [Abstract][Full Text] [Related]
16. Are standards and checklists needed in uremia therapy?
Shaldon S; Koch KM
Kidney Int Suppl; 1985 Dec; 17():S124-6. PubMed ID: 3867781
[No Abstract] [Full Text] [Related]
17. What is the role of expanded hemodialysis in renal replacement therapy in 2020?
Perez-Garcia R; Alcazar-Arroyo R; de Sequera-Ortiz P
Nefrologia (Engl Ed); 2021; 41(3):227-236. PubMed ID: 33685663
[No Abstract] [Full Text] [Related]
18. [Hepatitis C dissemination by hemodialysis: default isolation versus universal hygienic precautions (reply)].
Mauro MM; Ficaccio C
G Ital Nefrol; 2002; 19(1):82. PubMed ID: 12165951
[No Abstract] [Full Text] [Related]
19. Lethal copper intoxication in hemodialysis.
Matter BJ; Pederson J; Psimenos G; Lindeman RD
Trans Am Soc Artif Intern Organs; 1969; 15():309-15. PubMed ID: 5791402
[No Abstract] [Full Text] [Related]
20. Plasmapheresis holds distinct advantages for 21st century uremia therapy.
Nose Y; Smith JW; Malchesky PS
Kidney Int Suppl; 1985 Dec; 17():S131-2. PubMed ID: 3867783
[No Abstract] [Full Text] [Related]
[Next] [New Search]
